Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_assertion type Assertion NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_head.
- NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_assertion description "[It was also revealed that FOXA1 siRNA treatment of esophageal cancer cells reduced the mRNA level of both KRT7 and a stabilizer of epithelial-mesenchymal transition (EMT) regulator LOXL2, and that both FOXA1 and LOXL2 siRNAs reduced invasion and migration of ESCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_provenance.
- NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_assertion evidence source_evidence_literature NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_provenance.
- NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_assertion SIO_000772 20043065 NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_provenance.
- NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_assertion wasDerivedFrom befree-20150227 NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_provenance.
- NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_assertion wasGeneratedBy ECO_0000203 NP528628.RAGzJAwx46dyVwBKcBAzghkv0ZeWtBrgKyY3e8FV1ligs130_provenance.